Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941809 · ClinicalTrials.gov registry record · NA
Harnessing Placebo Effects in Methadone Treatment
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT02941809 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 133 participants.
The verdict
NCT02941809, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
More than 2 million individuals in the United States have an Opioid Use Disorder (OUD). Methadone maintenance treatment is the gold standard of medication-assisted treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. These adverse effects make enhancing the effectiveness of lower doses of methadone an attractive therapeutic goal. Long recognized for its capacity to enhance treatment outcomes for a wide range of neuropsychiatric disorders including pain, the placebo effect offers an as-yet untested avenue to such an enhancement. This approach is particularly compelling given that individuals with substance use disorder tend to have higher salience attribution, and may thereby be more sensitive to placebo effects. Our study combines two promising clinical methodologies-open-label placebo and conditioning-to investigate whether placebo effects can increase the effective potency of methadone in treatment-seeking OUD patients.
Interventions
- BEHAVIORAL Open-Label Placebo (OLP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941809
The ClinicalTrials.gov registry entry for NCT02941809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Open-Label Placebo (OLP) is the first listed.
NCT02941809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02941809 about?
NCT02941809 is a clinical study titled "Harnessing Placebo Effects in Methadone Treatment". More than 2 million individuals in the United States have an Opioid Use Disorder (OUD). Methadone maintenance treatment is the gold standard of medication-assisted treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. Th...
What is the current status of trial NCT02941809?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2017-12-05. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT02941809?
The interventions under investigation include: Open-Label Placebo (OLP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02941809?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.